Related Experiment Video
Updated: Jun 18, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Multi-omics characterization of type 2 diabetes associated genetic variation
Ravi Mandla1,2,3, Kim Lorenz4,5,6,7, Xianyong Yin8,9
1Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
This study integrates diverse genetic data to uncover mechanisms behind type 2 diabetes (T2D). Findings reveal key genes and metabolites influencing T2D risk and suggest new drug targets for treatment.
Area of Science:
- Genetics
- Metabolomics
- Systems Biology
Background:
- Understanding type 2 diabetes (T2D) pathophysiology is complex.
- Genome-wide association studies (GWAS) provide insights but require functional validation.
Purpose of the Study:
- To integrate multi-omics data with large-scale GWAS for T2D.
- To identify genes, metabolites, and traits associated with T2D risk.
- To elucidate T2D mechanisms and prioritize therapeutic targets.
Main Methods:
- Integrated 16 omics QTL studies and 46 GWAS with a large, ancestrally diverse T2D GWAS.
- Performed colocalization analysis to link GWAS variants with molecular traits.
- Constructed a gene-metabolite-trait network.
Main Results:
- 56% of T2D GWAS index variants colocalized with molecular traits.
- Identified 657 cis-effector genes, 1,691 distal-effector genes, and 731 metabolites.
- Highlighted the importance of diverse ancestry data for functional mapping.
- Revealed potential drug targets enriched for existing T2D therapies.
Conclusions:
- This integrated multi-omics approach significantly advances the molecular understanding of T2D genetic variation.
- The findings provide a foundation for developing novel therapeutic strategies for type 2 diabetes.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Genomics
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...